Friday, September 28
Breakfast
6:30 AM-7:45 AM

Friday, September 28
Lunch
11:45 AM-1:00 PM

Saturday, September 29
Breakfast
6:45 AM-8:00 AM

Saturday, September 29
Lunch
11:30 AM-12:45 PM

Sunday, September 30
Breakfast
7:00 AM-8:15 AM

Back to home

2007 Agenda: 2008 Agenda will be announced soon

SATURDAY, SEPTEMBER 29
Lunch, 11:30 AM-12:45 PM

Improving the Therapeutic Index of Taxane - Based Therapy

• Describe the rationale for developing a solvent-free, nanoparticle-sized, albumin-based drug delivery system

• Describe the results from clinical trials evaluating the efficacy and tolerability of nanoparticle albumin bound paclitaxel in patients with metastatic breast cancer

• Describe other novel, non-solvent based taxanes in clinical development

William Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Hope Rugo, MD
UCSF Comprehensive Cancer Center

Moderator
William Gradishar, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Supported by an educational grant from Abraxis BioScience and Astrazeneca
This activity has been approved for 1.25 AMA PRA Category 1 Credit(s)™.

Back to Top